Zuxokof-LS Sugar Free Syrup is a combination pharmaceutical formulation containing Levosalbutamol (1mg/5ml), Ambroxol (30mg/5ml), and Guaifenesin (50mg/5ml), designed for the symptomatic management of respiratory conditions associated with bronchospasm and mucus hypersecretion. Levosalbutamol, a selective β2-adrenergic receptor agonist, provides bronchodilation by relaxing the smooth muscles of the airways, thereby facilitating easier breathing in obstructive airway diseases such as asthma and chronic bronchitis. Ambroxol acts as a mucolytic agent, promoting the breakdown and clearance of viscous mucus, enhancing mucociliary transport, and aiding in the resolution of productive cough. Guaifenesin serves as an expectorant, increasing respiratory tract fluid secretions to loosen phlegm and reduce chest congestion. The sugar-free formulation of Zuxokof-LS Syrup is particularly suitable for diabetic patients or those requiring sugar-restricted diets. This combination therapy offers synergistic benefits by simultaneously addressing bronchoconstriction, mucus viscosity, and secretion clearance, thus improving overall respiratory function. Zuxokof-LS is indicated for use in adults and pediatric patients under medical supervision, with dosage adjustments as necessary based on clinical response and tolerability. It is contraindicated in patients with hypersensitivity to any component and should be used cautiously in individuals with cardiovascular disorders.